Submit Deal

ADAPTIMMUNE THERAPEUTICS PLC

HQ - Oxford

Summary

Adaptimmune is a biopharmaceutical company that develops T cell therapies against cancer.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 41 M

Avg. Deal Size£ 41 M

Market Context

Senior Management

Adrian Rawcliffe
CEO
Gavin Wood
CFO
Juli P. Miller
VP, Corporate Affairs and Investor Relations

Sort

goodwin procter

HQ - Boston

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

piper sandler

HQ - Minneapolis, Minnesota, United States

financial advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

joele frank

HQ - New York

pr advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

ropes & gray

HQ - Boston

legal advisors (2)

2 Shared Deals

2 For

£ 41 M

Total Value

td cowen

HQ - New York

financial advisors (2)

2 Shared Deals

2 For

£ 41 M

Total Value

white & case

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

mayer brown

HQ - Chicago

legal advisors (1)

1 Shared Deal

1 For

n/a

Total Value

gibson dunn & crutcher

HQ - Los Angeles

legal advisors (1)

1 Shared Deal

1 Opposite

£ 41 M

Total Value

oaktree capital management

debt providers (1)

1 Shared Deal

1 Opposite

£ 41 M

Total Value

athyrium capital management

HQ - New York

debt providers (1)

1 Shared Deal

1 Opposite

£ 41 M

Total Value

sullivan & cromwell

HQ - New York

legal advisors to debt providers (1)

1 Shared Deal

1 Opposite

£ 41 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy